Walk Before You Run: Feasibility Challenges and Lessons Learned from the PROCLAIM Study, a Multicenter Randomized Controlled Trial of Misoprostol for Prevention of Recurrent Clostridioides Difficile During COVID-19.
Anaerobe（2023）
Key words
difficile,Misoprostol,BioVU,PheWAS,Clostridioides difficile,Trial design
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined